James T. Obrien serves as Executive at DERMA SCIENCES, INC., where they oversee executive responsibilities. Since joining the company, James T. Obrien has executed 8 insider transactions totaling $176.0M, demonstrating a bullish approach to their equity position. Their most recent transaction on Mar 29, 2013 involved receiving (via award) 5,000 shares valued at $0.
James T. Obrien currently holds 53,542 shares of DERMA SCIENCES, INC. (DSCI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James T. Obrien has been a net buyer of DSCI stock. They have purchased $176.0M and sold $0 worth of shares.
James T. Obrien's most recent insider trade was on Mar 29, 2013, when they sold 5,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| May 31, 2012 | DSCI | $0 | Award | 3,000 | $N/A | Discretionary |
| May 27, 2012 | DSCI | $0 | Option Exercise | 2,500 | $N/A | Discretionary |
| Apr 16, 2012 | DSCI | $40.8K | Option Exercise | 10,000 | $4.08 | Discretionary |
| Apr 16, 2012 | DSCI | $40.8K | Payment | 4,658 | $8.76 | Discretionary |
| Jun 1, 2009 | DSCI | $0 | Award | 25,000 | $N/A | Discretionary |
| Sep 18, 2008 | DSCI | $176.0M | Purchase | 20,000 | $8800.00 | Discretionary |